$VRME
VerifyMe Inc Stock $vrme

$vrme Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000121465924018758 Filed on November 12, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$5.435M
YoY Change		-3.02%
Cost Of Revenue		$3.540M
YoY Change		6.88%
Gross Profit		$1.895M
YoY Change		-17.32%
Gross Profit Margin		34.87%
Selling, General & Admin		$1.179M
YoY Change		-62.48%
% of Gross Profit		62.22%
Research & Development		$5.000K
YoY Change		0.0%
% of Gross Profit		0.26%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$4.765M
YoY Change		51.41%
Operating Profit		-$2.870M
YoY Change		235.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$446.0K
YoY Change		-694.67%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		-$2.424M
YoY Change		160.65%
Net Earnings / Revenue		-44.6%
Basic Earnings Per Share		-$0.23
Diluted Earnings Per Share		-$0.23
COMMON SHARES
Basic Shares Outstanding	10.50M shares	10.38M shares
Diluted Shares Outstanding		10.60M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$2.610M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory		$19.00K
Prepaid Expenses
Receivables		$1.200M
Other Receivables
Total Short-Term Assets		$4.820M
YoY Change		-14.16%
LONG-TERM ASSETS
Property, Plant & Equipment		$159.0K
YoY Change		-40.0%
Goodwill		$3.988M
YoY Change		-24.94%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets		$10.01M
YoY Change		-24.12%
TOTAL ASSETS
Total Short-Term Assets		$4.820M
Total Long-Term Assets		$10.01M
Total Assets		$14.83M
YoY Change		-21.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$1.622M
YoY Change		8.35%
Accrued Expenses		$455.0K
YoY Change		-44.17%
Deferred Revenue
YoY Change
Short-Term Debt		$500.0K
YoY Change		0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$2.765M
YoY Change		-23.91%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.765M
Total Long-Term Liabilities
Total Liabilities		$4.549M
YoY Change		-34.14%
SHAREHOLDERS EQUITY
Retained Earnings		-$85.17M
YoY Change		4.06%
Common Stock		$11.00K
YoY Change		10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$464.0K
YoY Change		-37.97%
Treasury Stock Shares
Shareholders Equity		$10.28M
YoY Change
Total Liabilities & Shareholders Equity		$14.83M
YoY Change		-21.15%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$2.424M
YoY Change		160.65%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	377000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	999000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1403000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity File Number EntityFileNumber	001-39332
	dei	Entity Registrant Name EntityRegistrantName	VERIFYME, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Address Address Line1 EntityAddressAddressLine1	801 International Parkway
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Fifth Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lake Mary
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32746
	dei	City Area Code CityAreaCode	585
	dei	Local Phone Number LocalPhoneNumber	736-9400
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23000	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001104038
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-3023677
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10499541	shares
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2610000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3095000	usd
CY2024Q3	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	117000	usd
CY2023Q4	us-gaap	Accounts And Financing Receivable Allowance For Credit Loss AccountsAndFinancingReceivableAllowanceForCreditLoss	165000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1200000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3017000	usd
CY2024Q3	vrme	Unbilled Revenue UnbilledRevenue	786000	usd
CY2023Q4	vrme	Unbilled Revenue UnbilledRevenue	1282000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	205000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	254000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	19000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	38000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	4820000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	7686000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	159000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	240000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	339000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	468000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5523000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	3988000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5384000	usd
CY2024Q3	us-gaap	Assets Assets	14829000	usd
CY2023Q4	us-gaap	Assets Assets	20705000	usd
CY2024Q3	us-gaap	Debt Current DebtCurrent	500000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	500000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1622000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3310000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	455000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	988000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170000	usd
CY2024Q3	vrme	Contingent Liability Current ContingentLiabilityCurrent	22000	usd
CY2023Q4	vrme	Contingent Liability Current ContingentLiabilityCurrent	173000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2765000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5141000	usd
CY2023Q4	vrme	Contingent Liability Non Current ContingentLiabilityNonCurrent	751000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	184000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	307000	usd
CY2024Q3	vrme	Term Note TermNote	500000	usd
CY2023Q4	vrme	Term Note TermNote	875000	usd
CY2024Q3	vrme	Convertible Note Related Party ConvertibleNoteRelatedParty	450000	usd
CY2023Q4	vrme	Convertible Note Related Party ConvertibleNoteRelatedParty	475000	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	650000	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	625000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	4549000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8174000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10715065	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10453315	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10444698	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10123964	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	11000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95031000	usd
CY2024Q3	vrme	Treasury Stock Share TreasuryStockShare	270367	shares
CY2023Q4	vrme	Treasury Stock Share TreasuryStockShare	329351	shares
CY2024Q3	us-gaap	Treasury Stock Value TreasuryStockValue	464000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	659000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85172000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81849000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-86000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	10280000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	12531000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14829000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20705000	usd
CY2023Q3	us-gaap	Revenues Revenues	5604000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-930000	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2024Q3	us-gaap	Revenues Revenues	5435000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	3540000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	3558000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1895000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2046000	usd
CY2024Q3	us-gaap	Management Fee Expense ManagementFeeExpense	1329000	usd
CY2023Q3	us-gaap	Management Fee Expense ManagementFeeExpense	1341000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	778000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1178000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5000	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	401000	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	16	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q3	vrme	Contingent Liability Non Current ContingentLiabilityNonCurrent		usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill		usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	vrme	Leasehold Improvements LeaseholdImprovements		usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice
CY2024Q3	vrme	Sharebased Compensation Arrangement By Sharebased Payment Award Other Than Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOtherThanOptionsExercisableIntrinsicValue1		usd
CY2024Q3	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities		usd
CY2023Q4	vrme	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities		usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6927000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	95991000	usd
	us-gaap	Revenues Revenues	16546000	usd
	us-gaap	Revenues Revenues	16600000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	10301000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	11447000	usd
	us-gaap	Gross Profit GrossProfit	6245000	usd
	us-gaap	Gross Profit GrossProfit	5153000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	4189000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	3697000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2780000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3393000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5000	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	2252000	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	2265000	usd
	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	34000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	4765000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2901000	usd
	us-gaap	Operating Expenses OperatingExpenses	10298000	usd
	us-gaap	Operating Expenses OperatingExpenses	8550000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2870000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-855000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4053000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3397000	usd
CY2024Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-29000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-39000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-109000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-127000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
CY2024Q3	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	475000	usd
CY2023Q3	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	-36000	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	839000	usd
	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	136000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	446000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	730000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2424000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.35
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10603747	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9879202	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10306392	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9732619	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10603747	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9879202	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10306392	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9732619	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-2424000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-930000	usd
	us-gaap	Profit Loss ProfitLoss	-3323000	usd
	us-gaap	Profit Loss ProfitLoss	-3392000	usd
CY2024Q3	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	2000	usd
CY2023Q3	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	3000	usd
	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	7000	usd
	vrme	Change In Fair Value Of Interest Rate Swap ChangeInFairValueOfInterestRateSwap	4000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	42000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	28000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	91000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	76000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2464000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-955000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3407000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3464000	usd
	us-gaap	Profit Loss ProfitLoss	-3323000	usd
	us-gaap	Profit Loss ProfitLoss	-3392000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	49000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	174000	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	46000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2000	usd
	vrme	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	836000	usd
	vrme	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	136000	usd
	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-1009000	usd
	vrme	Fair Value Of Restricted Stock Awards And Restricted Stock Units Issued In Exchange For Services FairValueOfRestrictedStockAwardsAndRestrictedStockUnitsIssuedInExchangeForServices	-1053000	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	2261000	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	34000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	905000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	835000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	45000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-16000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1806000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3015000	usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	495000	usd
	vrme	Oprating Unbilled Revenue OpratingUnbilledRevenue	300000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-19000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-38000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-55000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2226000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2512000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	302000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-599000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	12000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	51000	usd
	vrme	Leasehold Improvements LeaseholdImprovements	8000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	363000	usd
	vrme	Deferred Implementation Costs DeferredImplementationCosts	58000	usd
	us-gaap	Payments For Software PaymentsForSoftware	334000	usd
	us-gaap	Payments For Software PaymentsForSoftware	576000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-353000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1080000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	800000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1100000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	21000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	80000	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	36000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	47000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	18000	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	1000	usd
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	10000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	375000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	675000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-438000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1277000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-485000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-404000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3095000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3411000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2610000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3007000	usd
	us-gaap	Interest Paid Net InterestPaidNet	160000	usd
	us-gaap	Interest Paid Net InterestPaidNet	129000	usd
	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap	7000	usd
	vrme	Noncash Change In Fair Value Of Interest Rate Swap NoncashChangeInFairValueOfInterestRateSwap	4000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	12358000	usd
CY2023Q3	vrme	Restricted Stock Awards Net Of Shares Withheld For Employee Tax RestrictedStockAwardsNetOfSharesWithheldForEmployeeTax	170000	usd
CY2023Q3	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	308000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	18000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-25000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-930000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	11899000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	12257000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	56000	usd
CY2024Q3	vrme	Restricted Stock Awards Net Of Shares Withheld For Employee Tax RestrictedStockAwardsNetOfSharesWithheldForEmployeeTax	345000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	86000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-40000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2424000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	10280000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13586000	usd
	vrme	Restricted Stock Awards Net Of Shares Withheld For Employee Tax RestrictedStockAwardsNetOfSharesWithheldForEmployeeTax	317000	usd
	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	718000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	127000	usd
	vrme	Common Stock Issued In Relation To Acquisition CommonStockIssuedInRelationToAcquisition	625000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	10000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-72000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	11899000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	12531000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	332000	usd
	vrme	Restricted Stock Units Net Of Shares Withheld For Employee Tax RestrictedStockUnitsNetOfSharesWithheldForEmployeeTax	630000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-84000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3323000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	10280000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_844_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zplBNpFi9sk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i><span style="text-decoration: underline"><span id="xdx_86D_zA1ACDaUIdh3">Reclassifications</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain amounts presented for the three and nine months ended September 30, 2023, reflect reclassifications made to conform to the presentation in our current reporting period. These reclassifications had no effect on the previously reported net loss.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2610000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3032000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	-0	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2610000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3095000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	63000	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	67	usd
	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	21	usd
	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	30	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_z5Nv7St7zYDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86B_zzEpjAIUtr3a">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8256000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8256000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8385000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8385000	shares
CY2024Q3	us-gaap	Revenues Revenues	5435000	usd
CY2023Q3	us-gaap	Revenues Revenues	5604000	usd
	us-gaap	Revenues Revenues	16546000	usd
	us-gaap	Revenues Revenues	16600000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1282000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1185000	usd
	vrme	Contract Asset Additions ContractAssetAdditions	6464000	usd
	vrme	Contract Asset Additions ContractAssetAdditions	5394000	usd
	vrme	Reclassification To Accounts Receivable Billed To Customers ReclassificationToAccountsReceivableBilledToCustomers	-6960000	usd
	vrme	Reclassification To Accounts Receivable Billed To Customers ReclassificationToAccountsReceivableBilledToCustomers	-5694000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	786000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	885000	usd
CY2023Q1	vrme	Business Combination Consideration Transferred BusinessCombinationConsiderationTransferred	360000	usd
CY2023Q1	vrme	Earnout Consideration EarnoutConsideration	1100000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	22000	usd
CY2024Q2	vrme	Contingent Consideration Payment ContingentConsiderationPayment	36000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	5384000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1351000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-45000	usd
CY2024Q3	us-gaap	Goodwill Gross GoodwillGross	3988000	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	901	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	914	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7730000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2207000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5523000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9006000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2079000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6927000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	277000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	266000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	817000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	761000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	914000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	257000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1023000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1023000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	996000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	622000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1602000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5523000	usd
CY2024Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	56000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	331000	usd
CY2023Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	177000	usd
	us-gaap	Restricted Stock Expense RestrictedStockExpense	325000	usd
CY2024Q3	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	345000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	678000	usd
CY2023Q3	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	316000	usd
	vrme	Stock Issued During Period Value Restricted Stock Award Net StockIssuedDuringPeriodValueRestrictedStockAwardNet	728000	usd
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	1750	shares
	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	38095	shares
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	30000	shares
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	42000	usd
CY2024Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	30000	shares
CY2024Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	42000	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	60000	shares
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	86000	usd
CY2024Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	270367	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	329351	shares
CY2024Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	464000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	659000	usd
CY2023Q4	us-gaap	Accelerated Share Repurchases Adjustment To Recorded Amount AcceleratedShareRepurchasesAdjustmentToRecordedAmount	500000	usd
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1000	shares
CY2024Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1000	usd
CY2024Q3	vrme	Unrecognized Compensation Cost Outstanding UnrecognizedCompensationCostOutstanding	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4628586	shares
CY2023Q4	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.13
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4628586	shares
CY2024Q3	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.13
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P1Y6M
CY2024Q3	vrme	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	4628586	shares
CY2024Q3	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice	4.13
	vrme	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercisable Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisableWeightedAverageRemainingContractualTerms	P1Y6M
CY2024Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	500000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	500000	usd
	vrme	Principal Outstanding PrincipalOutstanding	375000	usd
	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	0	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1958000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.07602	pure
CY2023Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	1100000	usd
CY2023Q3	vrme	Convertiable Promissory Notes Purchased By Related Party ConvertiablePromissoryNotesPurchasedByRelatedParty	475000	usd
CY2024Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	450000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	66000	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	1100000	usd
CY2024Q3	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2023Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.21	pure
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	50000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	47000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	145000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	132000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	13000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	23000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	54000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	52000	usd
	us-gaap	Lease Cost LeaseCost	158000	usd
	us-gaap	Lease Cost LeaseCost	155000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	339000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	468000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	184000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	307000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	350000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	477000	usd
CY2024Q3	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	144000	usd
CY2023Q4	vrme	Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities	177000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064	pure
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	48000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	196000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	139000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	45000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	428000	usd
CY2024Q3	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	78000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	350000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	184000	usd
CY2024Q3	us-gaap	Revenues Revenues	5435000	usd
CY2023Q3	us-gaap	Revenues Revenues	5604000	usd
	us-gaap	Revenues Revenues	16546000	usd
	us-gaap	Revenues Revenues	16600000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	1895000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2046000	usd
	us-gaap	Gross Profit GrossProfit	6245000	usd
	us-gaap	Gross Profit GrossProfit	5153000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	778000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1178000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2780000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3393000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	65000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	23000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2870000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-855000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4053000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3397000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	446000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	730000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2424000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-930000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3323000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3392000	usd
CY2024Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	54843	shares
CY2024Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	69667	shares
CY2024Q4	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	14824	shares
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
vrme-20240930_cal.xml	Edgar Link	unprocessable
0001214659-24-018758-index-headers.html	Edgar Link	pending
0001214659-24-018758-index.html	Edgar Link	pending
0001214659-24-018758.txt	Edgar Link	pending
0001214659-24-018758-xbrl.zip	Edgar Link	pending
ex10_3.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pnc_logo.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrme-20240930.xsd	Edgar Link	pending
y11524010q.htm	Edgar Link	pending
vrme-20240930_def.xml	Edgar Link	unprocessable
vrme-20240930_lab.xml	Edgar Link	unprocessable
vrme-20240930_pre.xml	Edgar Link	unprocessable
y11524010q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRME
VerifyMe Inc Stock $vrme

2024 Q4 Form 10-Q Financial Statement

#000121465924018758 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME VerifyMe Inc Stock $vrme

2024 Q4 Form 10-Q Financial Statement

#000121465924018758 Filed on November 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRME
VerifyMe Inc Stock $vrme